Atlas Trials

An Exploratory Study of Golidocitinib in Adult Patients With ITP

Clinical trial NCT07196163 · NOT_YET_RECRUITING

Trial details

NCT number
NCT07196163
Sponsor
Peking University People's Hospital
Status
NOT_YET_RECRUITING
Phase
Phase 1, Phase 2
Study type
INTERVENTIONAL
Immune Thrombocytopenia (ITP)
Start date
2025-10-30
Primary completion
2028-10-30
Enrollment
138

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.